1 Yoshida K，Takahashi JC，Takenobu Y，et al. Strokes

Associated With Pregnancy and Puerperium：A

Nationwide Study by the Japan Stroke Society[J].

Stroke，2017，48(2)：276-282.

2 Bushnell C，Mccullough L. Stroke prevention

in women：synopsis of the 2014 American Heart

Association/American Stroke Association guideline[J].

Ann Intern Med，2014，160(12)：853-857.

3 Liang CC，Chang SD，Lai SL，et al. Stroke

complicating pregnancy and the puerperium[J]. Eur J

Neurol，2006，13(11)：1256-1260.

4 Creary M，Williamson D，Kulkarni R. Sickle cell

disease：current activities，public health implications，

and future directions[J]. J Womens Health (Larchmt)，

2007，16(5)：575-582.

5 O'Neal MA，Feske SK. Stroke in pregnancy：a caseoriented

review[J]. Pract Neurol，2016，16(1)：23-34.

6 Osei EK，Faulkner K. Fetal doses from radiological

examinations[J]. Br J Radiol，1999，72(860)：773-780.

7 Chen MM，Coakley FV，Kaimal A，et al. Guidelines

for computed tomography and magnetic resonance

imaging use during pregnancy and lactation[J].

Obstetrics & Gynecology，2008，112(2 Pt 1)：333-340.

8 Mortimer AM，Bradley MD，Likeman M，et al.

Cranial neuroimaging in pregnancy and the postpartum

period[J]. Clin Radiol，2013，68(5)：500-508.

9 Crownover BK，Bepko JL. Appropriate and safe use

of diagnostic imaging[J]. Am Fam Physician，2013，

87(7)：494-501.

10 International Commission on Non-Ionizing Radiation

Protection. ICNIRP statement on diagnostic devices

using non-ionizing radiation：existing regulations and

potential health risks[J]. Health physics，2017，112(3)：

305-321.

11 Kanal E，Barkovich AJ，Bell C，et al. ACR guidance

document for safe MR practices：2007[J]. AJR Am J

Roentgenol，2007，188(6)：1447-1474.

12 Victoria T，Jaramillo D，Roberts TP，et al. Fetal

magnetic resonance imaging：jumping from 1.5 to 3

tesla (preliminary experience)[J]. Pediatr Radiol，2014，

44(4)：376-386.

13 Nelson JA，Livingston GK，Moon RG. Mutagenic

evaluation of radiographic contrast media[J]. Invest

Radiol，1982，17(2)：183-185.

14 Oh KY，Roberts VH，Schabel MC，et al. Gadolinium

Chelate Contrast Material in Pregnancy：Fetal

Biodistribution in the Nonhuman Primate[J].

Radiology，2015，276(1)：110-118.

15 Khawaja AZ，Cassidy DB，Al Shakarchi J，et al.

Revisiting the risks of MRI with Gadolinium based

contrast agents-review of literature and guidelines[J].

Insights Imaging，2015，6(5)：553-558.

16 Tettenborn B. Stroke and pregnancy[J]. Neurol Clin，

2012，30(3)：913-924.

17 Davie CA，O'brien P. Stroke and pregnancy[J]. J

Neurol Neurosurg Psychiatry，2008，79(3)：240-245.

18 Beroyz G，Casale R，Farreiros A，et al. CLASP-A

Randomized Trial Of Low-Dose Aspirin For The

Prevention And Treatment Of Preeclampsia Among

9364 Pregnant-Women[J]. Lancet，1994，343(8898)：

619-629.

19 Coomarasamy A，Honest H，Papaioannou S，et al.

Aspirin for prevention of preeclampsia in women

with historical risk factors：a systematic review[J].

Obstetrics & Gynecology，2003，101(6)：1319-1332.

20 Myers GR，Hoffman MK，Marshall ES. Clopidogrel

use throughout pregnancy in a patient with a drugeluting

coronary stent[J]. Obstet Gynecol，2011，118

(2 Pt 2)：432-443.

21 Sebastian C，Scherlag M，Kugelmass A，et al.

Primary stent implantation for acute myocardial

infarction during pregnancy：use of abciximab，

ticlopidine，and aspirin[J]. Cathet Cardiovasc Diagn，

1998，45(3)：275-279.

22 Boztosun B，Olcay A，Avci A，et al. Treatment

of acute myocardial infarction in pregnancy with

coronary artery balloon angioplasty and stenting：use

of tirofiban and clopidogrel[J]. Int J Cardiol，2008，

127(3)：413-426.

23 Del Zotto E，Giossi A，Volonghi I，et al. Ischemic

Stroke during Pregnancy and Puerperium[J]. Stroke

Res Treat，2011，2011：606780.

24 Sanson BJ，Lensing AW，Prins MH，et al. Safety

of low-molecular-weight heparin in pregnancy：a

systematic review[J]. Thromb haemost，1999，81(5)：

668-672.

25 Cotrufo M，De Feo M，De Santo LS，et al. Risk of

warfarin during pregnancy with mechanical valve

prostheses[J]. Obstetrics & Gynecology，2002，99(1)：

35-40.

26 Lison D，Van Maele-Fabry G，Gofflot F，et al. Effects

of retinoic acid，auranofin and mercuric chloride on

plasminogen activator activity in post-implantation

cultured mouse embryos[J]. Toxicol In Vitro，1993，

7(6)：751-755.

27 Selim MH，Molina CA. The Use of Tissue

Plasminogen-activator in Pregnancy A Taboo

Treatment or a Time to Think Out of the Box[J].

Stroke，2013，44(3)：868-869.

28 Murugappan A，Coplin W，Al-Sadat A，et al.

Thrombolytic therapy of acute ischemic stroke during

pregnancy[J]. Neurology，2006，66(5)：768-770.

29 Cronin C，Weisman C，Llinas R. Stroke Treatment[J].

Ann N Y Acad Sci，2008，1142：159-178.

30 Lumbers ER，Stevens A. Changes in fetal renal

function in response to infusions of a hyperosmotic

solution of mannitol to the ewe[J]. J Physiol，1983，

343：439-446.

31 Zaphiratos V，McKeen DM，Macaulay B，et al.

Persistent paralysis after spinal anesthesia for cesarean

delivery[J]. J Clin Anesth，2015，27(1)：68-72.

32 Burgess A，Vere D. Teratogenic effects of some

calcium channel blocking agents in Xenopus

embryos[J]. Pharmacol Toxicol，1989，64(1)：78-82.

33 Shainker SA，Edlow JA，O'Brien K. Cerebrovascular

emergencies in pregnancy[J]. Best Pract Res Clin

Obstet Gynaecol，2015，29(5)：721-731.

34 Dias MS，Sekhar LN. Intracranial hemorrhage from

aneurysms and arteriovenous malformations during

pregnancy and the puerperium[J]. Neurosurgery，1990，

27(6)：855-865.

35 Robba C，Bacigaluppi S，Bragazzi NL，et al.

Aneurysmal Subarachnoid Hemorrhage in Pregnancy-

Case Series，Review，and Pooled Data Analysis[J].

World Neurosurg，2016，88：383-398.

36 Sharshar T，Lamy C，Mas J L. Incidence and

causes of strokes associated with pregnancy and

puerperium[J]. Stroke，1995，26(6)：930-936.